How Kapsule Helps New Product Launches WHILE Keeping Cost Low! (Part 1)

How Kapsule Helps New Product Launches WHILE Keeping Cost Low! (Part 1)

For pharmaceutical companies, launching a branded product in a new market is a slow, expensive, and often risky process.?

Especially if you’re planning on launching a product in a market with an unknown Total Addressable Market (TAM), in addition to competition from both branded and generic alternatives.?

No market experiences these challenges more than the African market.?

Coincidentally, Africa is simultaneously the continent with the highest disease burden in the world, the fastest growing population, and the fastest growing middle class.?

Therefore it has all of the ingredients to be the most attractive to big pharma.?

Unfortunately when working in Africa, the promise of growth and expansion is often curtailed by reality. Pharmaceuticals are flying blind because they are missing sources of reliable key information to help their decision making.?

As a result, pharmaceuticals have two choices:

  1. Take a cautious approach and not register their products leaving money on the table but managing their risk.
  2. Use the best data that they have available to them and take the risk, launch their product, and then periodically review performance to see whether or not they made the right decision.

When contrasting those two options, none stands out as obviously superior, which is why the industry is split on the best approach.

But what if there was a third, and clearly superior, option??

One where you can have all of the data that you need to;

  • Know the financial viability of this new market before you enter, and
  • Have the ability to connect with the potential customers of your products (like hospitals, clinics, and insurers)

That’s precisely what Kapsule ’s data offers.?

We collate data from hospital systems, insurers, ERP software and healthtech datasets, from across the African market to give you that comprehensive view. We are aggressively growing and are already in 7 countries with plans to hit 20 in the coming months.

We make this data easily available and readily accessible to our customers.?

In part two I’ll delve into how having this kind of information at your fingertips can help you to keep your pre-launch costs low.

If you’re a pharmaceutical company that is curious to learn more about the data that Kapsule has available, or how we can help you pre-launch, feel free to reach out to me directly.

[email protected]

Does this effectively encourage closed-loop marketing?

要查看或添加评论,请登录

David Chen的更多文章

社区洞察

其他会员也浏览了